Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors


    South Korea: Navigating the Clinical Trial and Regulatory Environment - Webinar By GlobalCompliancePanel

    View: 205

    Website http://bit.ly/JuvSkz | Want to Edit it Edit Freely

    Category online training,Pharmacovigilance,Project structure,Business Process Management,compliance, safety perspectives,Business Process Optimization

    Deadline: May 01, 2012 | Date: May 01, 2012

    Venue/Country: Online Training, U.S.A

    Updated: 2012-04-17 13:03:24 (GMT+9)

    Call For Papers - CFP

    Overview: This course specifically focuses on the overall regulatory compliance requirements and procedures for Pharmaceutical Products in South Korea. The course will cover topics relating to pre-clinical and clinical requirements, as well as, addressing the structure of the regulatory agencies in South Korea. Content will also include descriptions of the methods by which regulators in the corresponding agencies process filings and registrations and what is expected in the authorization and dossier maintenance of licensed products.

    The current regulatory climate will be discussed in depth and several examples will be provided to illustrate effective compliance procedures and techniques. Common issues which have caused difficulties for Life Sciences firms will also be discussed. Course content will also explain how South Korea interacts with and utilizes ICH standards and how they relate with other national regulatory agencies.

    The course will also discuss how personnel can best address the conflicts that sometimes arise and the approach that can best be taken for resolution. This course will also be useful for sales or general management personnel who need an overview of the Regulatory Compliance requirements within South Korea and how best to consider the country into one's Business Strategy.

    Agenda of the Session:

    Overview of South Korea's Healthcare System

    South Korea’s Regulatory Agencies Structure and Responsibilities

    South Korean Drug Development Process

    Agency Review Process for Decision-Making

    Country Establishment Licensing & Procedures

    South Korea and ICH (International Conference on Harmonization)

    Requirements for Clinical Trials in South Korea

    The Changing KFDA

    Product Labeling Requirements

    Cultural Aspects - Working in South Korea

    Effectively working with the Regulators; Do's and Don'ts, Practical Experiences Shared

    Learning Objectives: This course is designed to provide an overview of the regulatory environment in South Korea and will provide training in:

    What is the Regulatory Structure in South Korea

    Understanding the specific procedures for Pharmaceutical Products

    How to begin your company involvement in South Korea

    Requirements for Clinical Trials in South Korea

    South Korean Drug Development Process

    The Changing KFDA

    Understanding the Local Culture: How to negotiate with the regulators

    Who will benefit: This course will be of benefit to regulatory personnel whose responsibilities require knowledge of South Korea's regulatory environment. Administrative staff responsible for ensuring compliance with regulatory filings and overall regulatory compliance requirements will also find this training highly relevant. Any sales or general management employee requiring an understanding of how regulations and compliance issues impact the organization will also benefit.

    Tuesday, May 1, 2012

    10:00 AM PDT | 01:00 PM EDT

    Price List:

    Live : $245.00

    Corporate live : $995.00

    Recorded : $295.00

    webinarsatglobalcompliancepanel.com

    http://www.globalcompliancepanel.com

    Phone: 800-447-9407

    Fax: 302-288-6884


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.